DEAR EDITOR, COVID-19 vaccines rely on next-generation vaccine platforms of which
safety profiles are, to date, not well characterized. Sporadic cases of GCA secondary to …

COVID‐19 vaccination is critical in frequently immunocompromised patients with rheumatoid
arthritis (RA). However, there is a question about the risk of RA flares following vaccination …

Dear Editor, COVID‑19 vaccination is a global effort. In Spain, over 79% of the population is
fully vaccinated and, although the benefits obtained from immunization clearly outweigh any …

In the past months, mass vaccination represented the turning point of the global battle
against the COVID-19 pandemic, an unprecedented challenge for physicians, healthcare …

A previously healthy 62-year-old Caucasian woman was referred to us with a 7–8 week
history of constitutional symptoms following vaccination against coronavirus disease 2019 …

Aim To analyze the clinical patterns of new‐onset inflammatory arthritis after COVID‐19
vaccination among patients without pre‐existing rheumatic or autoimmune diseases …

Objectives To determine whether giant cell arteritis and polymyalgia rheumatica (GCA/PMR)
represent independent risk factors for worse outcomes in COVID-19. Methods …

Objectives COVID-19 vaccines have been proven to be safe in the healthy population.
However, gaps remain in the evidence of their safety in patients with systemic autoimmune …

Immunoglobulin A (IgA) vasculitis is generally triggered by infectious causes, but it has also
been reported after immunisation with various vaccines. Herein, we report two cases of IgA …

We read with high interest the article by Manzo et al.[1] about SARS-CoV-2 triggering
polymyalgia rheumatica (PMR). SARS-CoV-2 triggering giant cell arteritis (GCA) have also …